Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads In FDA Actions
FDA Actions for January/February 2018
FDA Approves Firvanq for C.diff-associated Diarrhea, CutisPharma news release; 2018 Jan 29
FDA Expands Indication for Influenza Vaccine, GSK news release; 2018 Jan 11
FDA Actions for November/December 2017
FDA Approves Isentress for Tx of HIV in Newborns, Merck news release; 2017 Nov 29
FDA Approves First 2-Drug Regimen for HIV, FDA news release; 2017 Nov 21
FDA Approves Two-Dose Hep B Vaccine , Dynavax news release; 2017 Nov 9
Shingrix Approved for Prevention of Shingles, GSK news release; 2017 Oct 23
FDA Actions for September/October 2017
FDA Approves Zika Virus Screening Test , FDA news release; 2017 Oct 5
Solosec Approved for Bacterial Vaginosis, Symbiomix Therapeutics news release; 2017 Sep 18
New Approval for Treatment of Chagas Disease, FDA news release; 2017 Aug 29
FDA Approves New Antibacterial Drug, FDA news release; 2017 Aug 29
Kedrab Approved for Rabies Treatment, Kedrion news release; 2017 Aug 25
FDA Actions for July/August 2017
FDA Approves Mavyret for All HCV Genotypes, FDA news release; 2017 Aug 3
FDA Approves Updated Labeling for Epclusa, Gilead Sciences news release; 2017 Aug 1
FDA Approves Vosevi for Adults with HCV, FDA news release; 2017 July 18
FDA Actions for May/June 2017
FDA Approves Baxdela for Bacterial Skin Infections, Melinta Therapeutics news release; 2017 Jun 19
FDA Approves Isentress HD for HIV-1 Infection, Merck news release; 2017 May 30